SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 44 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $265,000 | -4.7% | 212,000 | 0.0% | 0.00% | – |
| Q1 2022 | $278,000 | -94.9% | 212,000 | -94.3% | 0.00% | -100.0% |
| Q4 2021 | $5,419,000 | -56.9% | 3,700,000 | -56.5% | 0.00% | -66.7% |
| Q3 2021 | $12,570,000 | +144.5% | 8,500,000 | +117.9% | 0.01% | +200.0% |
| Q2 2021 | $5,141,000 | +45.8% | 3,900,000 | +129.4% | 0.00% | 0.0% |
| Q3 2020 | $3,525,000 | -23.2% | 1,700,000 | -15.0% | 0.00% | -33.3% |
| Q2 2020 | $4,590,000 | +75.3% | 2,000,000 | +0.9% | 0.00% | +50.0% |
| Q3 2019 | $2,618,000 | -50.7% | 1,982,000 | -17.0% | 0.00% | -33.3% |
| Q2 2019 | $5,313,000 | +5.8% | 2,387,000 | -14.2% | 0.00% | 0.0% |
| Q1 2019 | $5,021,000 | – | 2,783,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |